HLA-B8 in patients with the Lambert-Eaton myasthenic syndrome reduces likelihood of associated small cell lung carcinoma.
Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands. pwwirtz@lumc.nl
Paul W
PW
Wirtz
Nick
N
Willcox
Bart O
BO
Roep
Bethan
B
Lang
Axel R
AR
Wintzen
John
J
Newsom-Davis
Jan J
JJ
Verschuuren
D018288:Carcinoma, Small Cell / Q000150:complications* / Q000235:genetics / Q000378:metabolism; D005787:Gene Frequency; D015795:HLA-B8 Antigen / Q000235:genetics / Q000378:metabolism*; D006801:Humans; D015624:Lambert-Eaton Myasthenic Syndrome / Q000150:complications* / Q000235:genetics / Q000378:metabolism; D011237:Predictive Value of Tests; D012680:Sensitivity and Specificity
D015795:HLA-B8 Antigen